Feras M Bader

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Large-vessel vasculitis in a cardiac allograft
    Feras Bader
    Department of Internal Medicine, Yale University Schoold of Medicine, Salt Lake City, Utah 84132, USA
    Can J Cardiol 21:745. 2005
  2. ncbi request reprint A rare case of pulmonary vein sarcoma
    Feras Bader
    University of Utah Health Sciences Centre, Salt Lake City, Utah, USA
    Can J Cardiol 21:839-40. 2005
  3. ncbi request reprint The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients
    Feras M Bader
    Heart Failure Transplantation, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    J Heart Lung Transplant 24:2144-7. 2005
  4. doi request reprint Noninvasive diagnosis of cardiac allograft rejection using echocardiography indices of systolic and diastolic function
    F M Bader
    Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Transplant Proc 43:3877-81. 2011
  5. doi request reprint Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure
    Feras M Bader
    Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Congest Heart Fail 16:265-70. 2010
  6. doi request reprint Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function
    Feras M Bader
    Division of Cardiology, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Congest Heart Fail 15:63-7. 2009
  7. doi request reprint A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah, USA
    J Heart Lung Transplant 31:46-51. 2012
  8. doi request reprint Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?
    Monica P Revelo
    George E Wahlen Veterans Affairs Medical Center, Utah Transplantation Affiliated Hospitals, Salt Lake City, Utah, USA
    J Heart Lung Transplant 30:144-50. 2011
  9. doi request reprint A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Utah, USA
    J Heart Lung Transplant 28:51-7. 2009
  10. doi request reprint Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, UT, USA
    J Heart Lung Transplant 28:781-4. 2009

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Large-vessel vasculitis in a cardiac allograft
    Feras Bader
    Department of Internal Medicine, Yale University Schoold of Medicine, Salt Lake City, Utah 84132, USA
    Can J Cardiol 21:745. 2005
  2. ncbi request reprint A rare case of pulmonary vein sarcoma
    Feras Bader
    University of Utah Health Sciences Centre, Salt Lake City, Utah, USA
    Can J Cardiol 21:839-40. 2005
    ..Pulmonary vein tumours are rare. They can cause significant morbidity and mortality. The present report discusses a rare case of pulmonary vein sarcoma in an elderly male patient...
  3. ncbi request reprint The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients
    Feras M Bader
    Heart Failure Transplantation, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    J Heart Lung Transplant 24:2144-7. 2005
    ..We evaluated the effects of carvedilol and metoprolol on CsA level when initiated in cardiac transplant recipients...
  4. doi request reprint Noninvasive diagnosis of cardiac allograft rejection using echocardiography indices of systolic and diastolic function
    F M Bader
    Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Transplant Proc 43:3877-81. 2011
    ..The purpose of our study was to evaluate various systolic and diastolic indices, including newer tissue Doppler imaging techniques, in diagnosing cardiac allograft rejection...
  5. doi request reprint Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure
    Feras M Bader
    Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Congest Heart Fail 16:265-70. 2010
    ..12). Enoximone is effective in improving the hemodynamics in patients with moderate to severe CHF and is tolerated at least as well as dobutamine...
  6. doi request reprint Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function
    Feras M Bader
    Division of Cardiology, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Congest Heart Fail 15:63-7. 2009
    ..BNP levels do predict allograft rejection but correlate with allograft function after 6 months following transplant...
  7. doi request reprint A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah, USA
    J Heart Lung Transplant 31:46-51. 2012
    ..Debate continues about whether therapeutic intervention is warranted to avoid adverse outcomes. In this study we examine the course of individual episodes of untreated asymptomatic AMR on follow-up endomyocardial biopsy (EMB)...
  8. doi request reprint Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?
    Monica P Revelo
    George E Wahlen Veterans Affairs Medical Center, Utah Transplantation Affiliated Hospitals, Salt Lake City, Utah, USA
    J Heart Lung Transplant 30:144-50. 2011
    ....
  9. doi request reprint A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Utah, USA
    J Heart Lung Transplant 28:51-7. 2009
    ..In this study, we hypothesized that the severity of AMR, as assessed on EMBs, correlates with cardiovascular mortality in heart transplant recipients...
  10. doi request reprint Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, UT, USA
    J Heart Lung Transplant 28:781-4. 2009
    ..In this study, we examined whether a differential impact on cardiovascular mortality (CVM) existed when comparing asymptomatic AMR, to stable MR or CR...
  11. ncbi request reprint Early screening for antibody-mediated rejection in heart transplant recipients
    Abdallah G Kfoury
    LDS Hospital and Intermountain Healthcare, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 26:1264-9. 2007
    ..In this study, we examine whether a pattern of repetitive AMR occurred early enough after transplantation to warrant prospective immunohistochemistry screening in all recently transplanted recipients...
  12. doi request reprint Allograft rejection in patients supported with continuous-flow left ventricular assist devices
    Aaron H Healy
    UTAH Utah Transplant Affiliated Hospitals Cardiac Transplant Program, University of Utah, Salt Lake City, Utah 84132, USA
    Ann Thorac Surg 92:1601-7; discussion 1607. 2011
    ..We sought to analyze the relationship between LVAD flow characteristics and subsequent allograft rejection in bridge to transplant (BTT) patients...
  13. pmc Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Omar Wever-Pinzon
    U T A H Cardiac Transplant Program, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Circulation 127:452-62. 2013
    ..Survival of patients on left ventricular assist devices (LVADs) has improved. We examined the differences in risk of adverse outcomes between LVAD-supported and medically managed candidates on the heart transplant waiting list...
  14. doi request reprint Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?
    Suman S Kuppahally
    Division of Cardiology, University of Utah, Salt Lake City, Utah, USA
    Am J Cardiol 106:1657-62. 2010
    ..However, in patients with borderline PVR, right-sided cardiac catheterization is indicated to assess eligibility for transplantation...
  15. ncbi request reprint Percutaneous coronary interventions with stents in cardiac transplant recipients
    Feras M Bader
    Department of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    J Heart Lung Transplant 25:298-301. 2006
    ..The aim of this study was to review our experience with percutaneous coronary intervention (PCI) with stents in cardiac transplant recipients...
  16. ncbi request reprint Initiation and use of beta-blockers in class IV heart failure
    Feras M Bader
    Division of Cardiology 4A100, University of Utah Health Sciences Center, 30 North 1900 East, Salt Lake City, UT 84132, USA
    Curr Heart Fail Rep 1:72-6. 2004
    ..Although treatment requires considerable care, the data support attempts at initiation of b-blockers in this group of patients...